Ashish Dandekar, from the Promoter Group of Camlin Fine Sciences Limited, has confirmed no new encumbrances on the shares held by the Promoter and Promoter Group for the financial year ended March 31, 2025, beyond previous disclosures. This assurance highlights the stability and commitment of the Promoter Group to their shareholding, potentially enhancing investor confidence in the company's governance and overall business outlook.